Ricardo Olímpio de Moura

Dr. Ricardo Olímpio de Moura

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RCRyldene Da Cruz
Ryldene Da Cruz
Francisco Mendonça JuniorFrancisco Mendonça Junior
Francisco Mendonça Junior
NMNatália Barbosa de Mélo
Natália Barbosa de Mélo
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
RARodrigo Santos Aquino de Araújo
Rodrigo Santos Aquino de Araújo
RMRicardo Olímpio de Moura
Ricardo Olímpio de Moura
Rheumatoid arthritis, arthrosis and gout, among other chronic inflammatory diseases are public health problems and represent major therapeutic challenges. Non-steroidal anti-inflammatory drugs (NSAIDs) are the most prescribed clinical treatments, despite their severe side effects and their exclusive action in improving symptoms, without effectively promoting the cure. However, recent advances in the fields of pharmacology, medicinal chemistry, and chemoinformatics have provided valuable information and opportunities for development of new anti-inflammatory drug candidates. For drug design and discovery, thiophene derivatives are privileged structures. Thiophene-based compounds, like the commercial drugs Tinoridine and Tiaprofenic acid, are known for their anti-inflammatory properties. The present review provides an update on the role of thiophene-based derivatives in inflammation. Studies on mechanisms of action, interactions with receptors (especially against cyclooxygenase (COX) and lipoxygenase (LOX)), and structure-activity relationships are also presented and discussed. The results demonstrate the importance of thiophene-based compounds as privileged structures for the design and discovery of novel anti-inflammatory agents. The studies reveal important structural characteristics. The presence of carboxylic acids, esters, amines, and amides, as well as methyl and methoxy groups, has been frequently described, and highlights the importance of these groups for anti-inflammatory activity and biological target recognition, especially for inhibition of COX and LOX enzymes.

Verified
Journal Article
Open access
PDF file
SASinara Mônica Vitalino De Almeida
Sinara Mônica Vitalino De Almeida
ELElizabeth Almeida Lafayette
Elizabeth Almeida Lafayette
LSLúcia Patrícia Bezerra Gomes Da Silva
Lúcia Patrícia Bezerra Gomes Da Silva
CACézar Augusto da Cruz Amorim
Cézar Augusto da Cruz Amorim
TOTiago Bento De Oliveira
Tiago Bento De Oliveira
LCLuiz Carvalho
Luiz Carvalho
In this work, the acridine nucleus was used as a lead-compound for structural modification by adding different substituted thiosemicarbazide moieties. Eight new (Z)-2-(acridin-9-ylmethylene)-N-phenylhydrazinecarbothioamide derivatives (3a–h) were synthesized, their antiproliferative activities were evaluated, and DNA binding properties were performed with calf thymus DNA (ctDNA) by electronic absorption and fluorescence spectroscopies. Both hyperchromic and hypochromic effects, as well as red or blue shifts were demonstrated by addition of ctDNA to the derivatives. The calculated binding constants ranged from 1.74 × 104 to 1.0 × 106 M−1 and quenching constants from −0.2 × 104 to 2.18 × 104 M−1 indicating high affinity to ctDNA base pairs. The most efficient compound in binding to ctDNA in vitro was (Z)-2-(acridin-9-ylmethylene)-N- (4-chlorophenyl) hydrazinecarbothioamide (3f), while the most active compound in antiproliferative assay was (Z)-2-(acridin-9-ylmethylene)-N-phenylhydrazinecarbothioamide (3a). There was no correlation between DNA-binding and in vitro antiproliferative activity, but the results suggest that DNA binding can be involved in the biological activity mechanism. This study may guide the choice of the size and shape of the intercalating part of the ligand and the strategic selection of substituents that increase DNA-binding or antiproliferative properties.

10 May 2023 in Molecules
Verified
Journal Article
Open access
PDF file
FLFernando Leite
Fernando Leite
Natália Ferreira De SousaNatália Ferreira De Sousa
Natália Ferreira De Sousa
BOBruno Hanrry Melo de Oliveira
Bruno Hanrry Melo de Oliveira
GDGabrielly Duarte
Gabrielly Duarte
MFMaria Denise Leite Ferreira
Maria Denise Leite Ferreira
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
Chalcones are direct precursors in the biosynthesis of flavonoids. They have an α,β-unsaturated carbonyl system which gives them broad biological properties. Among the biological properties exerted by chalcones, their ability to suppress tumors stands out, in addition to their low toxicity. In this perspective, the present work explores the role of natural and synthetic chalcones and their anticancer activity in vitro reported in the last four years from 2019 to 2023. Moreover, we carried out a partial least square (PLS) analysis of the biologic data reported for colon adenocarcinoma lineage HCT-116. Information was obtained from the Web of Science database. Our in silico analysis identified that the presence of polar radicals such as hydroxyl and methoxyl contributed to the anticancer activity of chalcones derivatives. We hope that the data presented in this work will help researchers to develop effective drugs to inhibit colon adenocarcinoma in future works.

6 December 2013 in Molecules
Verified
Journal Article
Open access
PDF file
ELElizabeth Almeida Lafayette
Elizabeth Almeida Lafayette
SASinara Mônica Vitalino De Almeida
Sinara Mônica Vitalino De Almeida
MPMarina Galdino Da Rocha Pitta
Marina Galdino Da Rocha Pitta
EBEduardo Isidoro Carneiro Beltrão
Eduardo Isidoro Carneiro Beltrão
TGTeresinha Gonçalves-Silva
Teresinha Gonçalves-Silva
MLMaria Do Carmo Alves de Lima
Maria Do Carmo Alves de Lima
Thiazacridine and imidazacridine derivatives have shown promising results as tumors suppressors in some cancer cell lines. For a better understanding of the mechanism of action of these compounds, binding studies of 5-acridin-9-ylmethylidene-3-amino-2-thioxo-thiazolidin-4-one, 5-acridin-9-ylmethylidene-2-thioxo-thiazolidin-4-one, 5-acridin-9-ylmethylidene-2-thioxo-imidazolidin-4-one and 3-acridin-9-ylmethyl-thiazolidin-2,4-dione with calf thymus DNA (ctDNA) by electronic absorption and fluorescence spectroscopy and circular dichroism spectroscopy were performed. The binding constants ranged from 1.46 × 104 to 6.01 × 104 M−1. UV-Vis, fluorescence and circular dichroism measurements indicated that the compounds interact effectively with ctDNA, both by intercalation or external binding. They demonstrated inhibitory activities to human topoisomerase I, except for 5-acridin-9-ylmethylidene-2-thioxo-1,3-thiazolidin-4-one. These results provide insight into the DNA binding mechanism of imidazacridines and thiazacridines.

Verified
Journal Article
Open access
PDF file
RARodrigo S. A. De Araújo
Rodrigo S. A. De Araújo
FGFelipe GUERRA
Felipe GUERRA
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
CSCarlos A. De Simone
Carlos A. De Simone
JTJosean Tavares
Josean Tavares
JFJose Maria Barbosa Filho
Jose Maria Barbosa Filho
The increased incidence of opportunistic fungal infections, associated with greater resistance to the antifungal drugs currently in use has highlighted the need for new solutions. In this study twenty four coumarin derivatives were screened in vitro for antifungal activity against strains of Aspergillus. Some of the compounds exhibited significant antifungal activity with MICs values ranging between 16 and 32 µg/mL. The structure-activity relationships (SAR) study demonstrated that O-substitutions are essential for antifungal activity. It also showed that the presence of a short aliphatic chain and/or electron withdrawing groups (NO2 and/or acetate) favor activity. These findings were confirmed using density functional theory (DFT), when calculating the LUMO density. In Principal Component Analysis (PCA), two significant principal components (PCs) explained more than 60% of the total variance. The best Partial Least Squares Regression (PLS) model showed an r2 of 0.86 and q2cv of 0.64 corroborating the SAR observations as well as demonstrating a greater probe N1 interaction for active compounds. Descriptors generated by TIP correlogram demonstrated the importance of the molecular shape for antifungal activity.

1 November 2022 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Igor José dos Santos NascimentoIgor José dos Santos Nascimento
Igor José dos Santos Nascimento
ÉRÉrica Erlanny da Silva Rodrigues
Érica Erlanny da Silva Rodrigues
MSManuele Figueiredo da Silva
Manuele Figueiredo da Silva
JAJoão X Araújo-Júnior
João X Araújo-Júnior
RMRicardo Olímpio de Moura
Ricardo Olímpio de Moura
The Flaviviridae virus family consists of the genera Hepacivirus, Pestivirus, and Fla-vivirus, with approximately 70 viral types that use arthropods as vectors. Among these diseases, dengue (DENV) and zika virus (ZIKV) serotypes stand out, responsible for thousands of deaths worldwide. Due to the significant increase in cases, the World Health Organization (WHO) declared DENV a potential threat for 2019 due to being transmitted by infected travelers. Furthermore, ZIKV also has a high rate of transmissibility, highlighted in the outbreak in 2015, generating consequenc-es such as Guillain-Barré syndrome and microcephaly. According to clinical outcomes, those in-fected with DENV can be asymptomatic, and in other cases, it can be lethal. On the other hand, ZIKV has severe neurological symptoms in newborn babies and adults. More serious symptoms in-clude microcephaly, brain calcifications, intrauterine growth restriction, and fetal death. Despite these worrying data, no drug or vaccine is approved to treat these diseases. In the drug discovery process, one of the targets explored against these diseases is the NS2B-NS3 complex, which pre-sents the catalytic triad His51, Asp75, and Ser135, with the function of cleaving polyproteins, with specificity for basic amino acid residues, Lys- Arg, Arg-Arg, Arg-Lys or Gln-Arg. Since NS3 is highly conserved in all DENV serotypes and plays a vital role in viral replication, this complex is an excellent drug target. In recent years, computer-aided drug discovery (CADD) is increasingly essen-tial in drug discovery campaigns, making the process faster and more cost-effective, mainly ex-plained by discovering new drugs against DENV and ZIKV. Finally, the main advances in compu-tational methods applied to discover new compounds against these diseases will be presented here. In fact, molecular dynamics simulations and virtual screening is the most explored approach, providing several hit and lead compounds that can be used in further optimizations. In addition, fragment-based drug design and quantum chemistry/molecular mechanics (QM/MM) provides new insights for developing anti-DENV/ZIKV drugs. We hope that this review offers further helpful in-formation for researchers worldwide and stimulates the use of computational methods to find a promising drug for treating DENV and ZIKV.